Page last updated: 2024-11-06

ocfentanil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID60575
CHEMBL ID2110917
CHEBI ID183384
SCHEMBL ID488987
MeSH IDM0193947

Synonyms (25)

Synonym
ocfentanil
CHEBI:183384
101343-69-5
n-(2-luorophenyl)-2-methoxy-n-[1-(2-phenylethyl)piperidin-4-yl]acetamide
ocfentanilo [inn-spanish]
ocfentanilum
acetamide, n-(2-fluorophenyl)-2-methoxy-n-(1-(2-phenylethyl)-4-piperidinyl)-
mx52wbc8ev ,
ocfentanilo
ocfentanil [inn]
unii-mx52wbc8ev
ocfentanilum [inn-latin]
n-(2-fluorophenyl)-2-methoxy-n-(1-(2-phenylethyl)-4-piperidinyl)acetamide
ocfentanyl
a 3217
2'-fluoro-2-methoxy-n-(1-phenethyl)-4-piperidyl)acetanilide
SCHEMBL488987
CHEMBL2110917
n-(2-fluorophenyl)-2-methoxy-n-[1-(2-phenylethyl)piperidin-4-yl]acetamide
AC-25508
AKOS025401778
Q7076285
a-3217;a 3217;a3217
BCP12723
DTXSID00869356

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Among these problems, of the highest relevance is also the lack of information about metabolism and adverse effects, which must be faced using simple and low-cost animal models."( Toxicity and behavioural effects of ocfentanil and 2-furanylfentanyl in zebrafish larvae and mice.
Arfè, R; Bilel, S; Gottardo, R; Marti, M; Murari, M; Pesavento, S; Tagliaro, F; Tirri, M; Torroni, L, 2023
)
1.19
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
anilideAny aromatic amide obtained by acylation of aniline.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's0 (0.00)29.6817
2010's7 (70.00)24.3611
2020's2 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (10.00%)5.53%
Reviews1 (10.00%)6.00%
Case Studies3 (30.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (50.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]